EVELYN KAMMIN: Open Payments
NPI 1174979264 · WESTMONT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 102 payments from 28 companies in 2025. Trend: 2023 $2,058 · 2024 $2,093 · 2025 $2,311
Food & beverage: $2,239Education: $72
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $457 |
| GlaxoSmithKline, LLC. | 15 | $329 |
| Regeneron Healthcare Solutions, Inc. | 9 | $177 |
| Inspire Medical Systems, Inc. | 3 | $143 |
| Viatris Specialty LLC | 5 | $104 |
| Verona Pharma, Inc. | 5 | $101 |
| Neurocrine BioSciences, Inc. | 3 | $89 |
| Phathom Pharmaceuticals, Inc. | 3 | $85 |
| Insmed, Inc. | 4 | $83 |
| Tandem Diabetes Care, Inc. | 4 | $71 |
Products named: TEZSPIRE, NUCALA, DUPIXENT, INSPIRE, TRELEGY ELLIPTA, YUPELRI, Ohtuvayre, CRENESSITY.
Industry payments across IL — which companies pay providers there.
